FindMyKOL

Ronnie Luyun, MD

Basic profile

University of Illinois Urbana-Champaign

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionUrbana, IL · MidwestSpecialtyMedical OncologyFocusOncology
Active KOLFindMyKOL type: RegionalLatest publication2013Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ronnie Luyun is an Oncology physician affiliated with University of Illinois Urbana-Champaign. OpenAlex indexes 7 publications with 830 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Publications indexed by OpenAlex. Counts exclude supporting files.

830citations

Citations across these publications.

5h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
19companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Astellas Pharma US Inc
    Program year20251 payment
    $100
  • PFIZER INC.
    Program year20252 payments
    $38
  • Eisai Inc.
    Program year20251 payment
    $24
All 30 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    32.3%
    Aromatase Inhibitor10.8%
    Letrozole58%Anastrozole37%Exemestane5%
    Part D<11 patients
    Cytochrome P450 17A1 Inhibitor9.6%
    Abiraterone Acetate100%
    Part D≥27 patients

    + 6 more classes in this area

  • Nervous system

    22.5%
    Opioid Agonist7.9%
    Oxycodone Hcl52%Morphine Sulfate Er18%Oxycodone-Acetaminophen16%Fentanyl8%Oxycontin7%
    Part D<11 patients
    Phenothiazine6.4%
    Prochlorperazine Maleate100%
    Part D≥89 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    22.1%
    Corticosteroid9.2%
    Prednisone100%
    Part D≥45 patients
    Serotonin-3 Receptor Antagonist4.1%
    Ondansetron Hcl86%Ondansetron Odt14%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”